The looming government shutdown will likely slow the pace of work at the FDA. The federal government will shut down…
Read More →
Not only is the People’s Republic of China (PRC) a threat with its use of TikTok, but it also supports…
Read More →
Artificial Intelligence (AI) is not just a technological innovation; it’s a transformative force that has permeated multiple sectors, from healthcare…
Read More →
Are you a diabetes patient who took Ozempic? Did you take Wegovy in hopes of losing weight? Have you suffered…
Read More →
Recently, U.S. lawmakers put Amazon and its top executives on the hot seat, raising questions about the retail giant’s commitment…
Read More →
Case Name: In re Sugammadex, No. 20-CV-2576 (CCC/LDW), 2023 WL 3966146 (D.N.J. June 13, 2023) (Cecchi, J.) Drug Product and…
Read More →
The U.S. Department of Homeland Security (DHS) announced new policies on September 14, 2023, regarding its use and acquisition of…
Read More →
On August 28, 2023, the California Privacy Protection Agency (the “Agency”) released two sets of draft regulations under the California…
Read More →
The UK-US data bridge is the UK Government’s preferred terminology to describe its decision to permit the flow of personal…
Read More →
On January 18, 2022, Microsoft’s acquisition of Activision, one of the world’s most-valuable gaming companies, was announced. In April 2023,…
Read More →